We are currently reviewing potential Wellbutrin® lawsuits involving women who took Wellbutrin® during early pregnancy and suffered adverse side effects. Wellbutrin®, an antidepressant prescription drug generically called Bupropion hydrochloride, has been linked in a recent study to serious side effects in women who take this drug during early pregnancy. This study, published in the American Journal of Obstetrics and Gynecology, suggests that women who take Wellbutrin during early pregnancy may run a greater risk for having a child born with a heart birth defect. This includes left outflow heart defects.
Bupropion is marketed as Wellbutrin®, Wellbutrin XL®, and Wellbutrin XR®.
Congenital heart defects affect approximately 40,000 babies each year, and one of the primary known causes of these birth defects is ingestion of teratogenic drugs during pregnancy. A teratogen is a drug or other substance capable of interfering with the development of a fetus that can ultimately result in serious birth defects.
Manufactured by GlaxoSmithKline, Bupropion hydrochloride is used to treat Major Depressive Disorder and Seasonal Affective Disorder. First approved by the FDA in 1985, Bupropion hydrochloride was available for several years only under the brand name Wellbutrin®. In 1996, the FDA aproved a sustained-release tablet of this drug called Wellbutrin SR® and, in 2003, approved an extended-release tablet known as Wellbutrin XL®.
If you or a loved one took Wellbutrin® during early pregnancy and had a child born with a birth defect, this side effect may be associated with Wellbutrin®. Attorneys Tim Edwards and Ed Wallis are currently reviewing potential Wellbutrin lawsuits. If you have a question or have suffered serious side effects, call us immediately for a free case evaluation and no obligation and no cost consultation:
TELEPHONE: 1-800-632-1404
EMAIL: click here
FILL OUT THIS FORM:
